Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03842293
Other study ID # 17-013723
Secondary ID 1U19AR069525
Status Completed
Phase
First received
Last updated
Start date June 22, 2017
Est. completion date August 30, 2020

Study information

Verified date November 2020
Source Children's Hospital of Philadelphia
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the clinical validity of a set of PROMIS pediatric person-reported outcome measures in patients with chronic kidney disease. The evaluation includes longitudinal assessments of how measures change in association with clinical changes.


Description:

The National Institutes of Health (NIH)-sponsored Patient-Reported Outcomes Measurement Information System (PROMIS) network has developed over 20 pediatric instruments, both child-report and parent-proxy editions. Cross-sectional evaluations of the validity of the instruments have established that they are ready for integration into clinical research and practice. The next step in their ongoing evaluation is to assess their prospective clinical validity in a variety of health conditions. This study addresses the clinical evaluation of the measures in children with chronic kidney disease (CKD). Through baseline surveys and six follow-up surveys over a two-year period, Investigators are collecting self-report (child) and parent-proxy report of 11 pediatric PROMIS measures. Each of these PROMIS measures is described in the Main Outcome Measures section. Investigators are also collecting assessments of disease activity from clinical data. The selection of self-report and parent proxy patient-reported outcome (PRO) measures were determined through qualitative content validation. The analytic goal of this project is to evaluate baseline (cross-sectional) and longitudinal associations between PROMIS pediatric outcome measures and changes in the clinical status of patients with CKD. Our primary hypothesis is that as kidney function declines, self-reported health will worsen.


Recruitment information / eligibility

Status Completed
Enrollment 213
Est. completion date August 30, 2020
Est. primary completion date August 30, 2020
Accepts healthy volunteers
Gender All
Age group 8 Years to 21 Years
Eligibility Inclusion Criteria: - Child is 8-21 years old at time of enrollment - Child is a Chronic Kidney Disease in Children (CKiD) patient OR a child who receives pediatric nephrology care at a CKiD site that participates in PEDSnet, a national pediatric learning health system - Child seen by a pediatric nephrologist in the past 24 months - Child has two eGFR readings (computed from serum creatinine) between 6-89 ml/min at least 3 months apart (eGFR of this level indicates CKD) - Child speaks English - Parent is the parent or legal guardian for the child - Parent speaks English Exclusion Criteria: - Child is currently receiving dialysis - Child received a kidney transplant - Child has a parent-reported cognitive limitation that would preclude them from completing a questionnaire - Child does not speak English - Parent does not speak English - Parent is not the parent of legal guardian for the child

Study Design


Locations

Country Name City State
Canada Children's Hospital Research Institute of Manitoba Winnipeg Manitoba
United States University of Michigan, Mott Hospital Ann Arbor Michigan
United States Children's Healthcare of Atlanta Atlanta Georgia
United States Johns Hopkins Children's Center Baltimore Maryland
United States Children's Hospital of Alabama Birmingham Alabama
United States Levine Children's Charlotte North Carolina
United States Cincinnati Children's Hospital and Medical Center Cincinnati Ohio
United States Cleveland Clinic Cleveland Ohio
United States Nationwide Children's Hopsital Columbus Ohio
United States Riley Hospital for Children Indianapolis Indiana
United States Children's Mercy Hospital Kansas City Missouri
United States UCLA Los Angeles California
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Oregon Health and Science University Portland Oregon
United States St. Louis Children's Hospital Saint Louis Missouri
United States Seattle Children's Hospital Seattle Washington

Sponsors (2)

Lead Sponsor Collaborator
Children's Hospital of Philadelphia National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Longitudinal change in sleep disturbance Child self-report of 8 items from PROMIS sleep-related disturbance domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in sleep-related impairment Child self-report of 4 items from PROMIS sleep-related impairment domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in fatigue Child self-report of 8 items from PROMIS fatigue domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in life satisfaction Child self-report of 4 items from from PROMIS life satisfaction domain. Participants rate their experience using a five point scale ranging from not at all to quite a bit. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in meaning and purpose Child self-report of 4 items from from PROMIS meaning and purpose domain. Participants rate their experience using a five point scale ranging from not at all to quite a bit. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in psychological stress experiences Child self-report of 4 items from from PROMIS psychological stress experiences domain. Participants rate their experience using a five point scale ranging from not at all to quite a bit. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in global health Parent proxy report of 7 items from from PROMIS global health domain. Parents rate their child's experience using a five point scale ranging from poor to excellent. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in depressive symptoms Parent proxy report of 4 items from from PROMIS emotional distress - depressive symptoms domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in anxiety Parent proxy report of 4 items from from PROMIS emotional distress - anxiety domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in positive affect Parent proxy report of 4 items from from PROMIS positive affect domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
Primary Longitudinal change in family relationships Parent proxy report of 4 items from from PROMIS family relationships domain. Parents rate their child's experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. Baseline and 3 month, 6 month, 12 month, 15 month, 18 month and 24 month follow-ups.
See also
  Status Clinical Trial Phase
Recruiting NCT06386172 - Electronic Decision-support System to Improve Detection and Care of Patients With Chronic Kidney Disease in Stockholm N/A
Recruiting NCT04910867 - APOL1 Genetic Testing Program for Living Donors N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Terminated NCT05022329 - COVID-19 Vaccine Boosters in Patients With CKD Phase 2/Phase 3
Not yet recruiting NCT04925661 - HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia Phase 1
Recruiting NCT04961164 - Resistant Starch Prebiotic Effects in Chronic Kidney Disease N/A
Completed NCT05015647 - Low Protein Diet in CKD Patients at Risk of Malnutrition N/A
Completed NCT03426787 - Helping Empower Liver and Kidney Patients N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Completed NCT04363554 - The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease N/A
Recruiting NCT04831021 - Pre- or Per-dialytic Physical Exercise : a Cardioprotective Role? N/A
Terminated NCT04877847 - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury N/A
Recruiting NCT04422652 - Combination of Novel Therapies for CKD Comorbid Depression Phase 2
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Not yet recruiting NCT06330480 - Check@Home: General Population Screening for Early Detection of Atrial Fibrillation and Chronic Kidney Disease N/A
Recruiting NCT03176862 - Left Ventricular Fibrosis in Chronic Kidney Disease N/A
Terminated NCT02539680 - Intestinal Phosphate Transporter Expression in CKD Patients N/A